Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Quarterly results
CC transcript
Asset disposition
ARIAD PHARMACEUTICALS INC (ARIA) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/16/2017 8-K Quarterly results
02/06/2017 8-K Form 8-K - Current report
01/10/2017 8-K Form 8-K - Current report
12/08/2016 8-K Form 8-K - Current report
12/07/2016 8-K Form 8-K - Current report
11/30/2016 8-K Form 8-K - Current report
11/18/2016 8-K Form 8-K - Current report
11/07/2016 8-K Form 8-K - Current report
10/31/2016 8-K Form 8-K - Current report
09/29/2016 8-K Other Events, Financial Statements and Exhibits
Docs: "ARIAD Announces Regulatory Approval for Iclusig ® in Japan"
08/30/2016 8-K Other Events, Financial Statements and Exhibits
Docs: "ARIAD Completes Rolling Submission of New Drug Application for Brigatinib to the U.S. Food and Drug Administration"
07/28/2016 8-K Form 8-K - Current report
07/22/2016 8-K Form 8-K - Current report
06/07/2016 8-K Form 8-K - Current report
06/02/2016 8-K Form 8-K - Current report
05/26/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "ARIAD ANNOUNCES APPOINTMENT OF JENNIFER L. HERRON AS CHIEF COMMERCIAL OFFICER"
05/20/2016 8-K Form 8-K - Current report
05/19/2016 8-K Other Events, Financial Statements and Exhibits
Docs: "ARIAD Announces Data Presentations at the 2016 ASCO Annual Meeting"
05/10/2016 8-K Form 8-K - Current report
05/09/2016 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "INCYTE AND ARIAD ANNOUNCE AGREEMENT FOR INCYTE TO ACQUIRE ARIAD'S EUROPEAN OPERATIONS AND IN-LICENSE ICLUSIG ® IN EUROPE"
05/06/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/25/2016 8-K Form 8-K - Current report
03/29/2016 8-K Form 8-K - Current report
03/18/2016 8-K Form 8-K - Current report
03/14/2016 8-K Form 8-K - Current report
02/23/2016 8-K Quarterly results
Docs: "ARIAD Reports 2015 Financial Results, Provides 2016 Product Revenue Guidance and Outlines Company Progress"
01/13/2016 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Results of Operations and Financi...
Docs: "Certificate of Elimination of Series A Junior Participating Preferred Stock of ARIAD Pharmaceuticals, Inc",
"Certificate of Elimination of Series B Convertible Preferred Stock of ARIAD Pharmaceuticals, Inc",
"Certificate of Elimination of Series C Convertible Preferred Stock of ARIAD Pharmaceuticals, Inc",
"Restated Certificate of Incorporation of ARIAD Pharmaceuticals, Inc",
"Second Amendment to Section 382 Rights Agreement, between ARIAD Pharmaceuticals, Inc. and Computershare Trust Company, N.A., as Rights Agent",
"ARIAD Pharmaceuticals, Inc. Presentation for the 34th Annual J.P. Morgan Healthcare Conference dated January 2016",
"ARIAD ANNOUNCES ELECTION OF ALEX DENNER AS CHAIRMAN OF THE BOARD OF DIRECTORS",
"ARIAD ANNOUNCES TERMINATION OF SHAREHOLDER RIGHTS PLAN"
12/18/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement dated December 16, 2015, between ARIAD Pharmaceuticals, Inc. and Paris Panayiotopoulos",
"Form of Restricted Stock Unit Agreement (Inducement Grant)",
"Form of Stock Option Agreement (Inducement Grant)",
"Cambridge, MA, December 18, 2015–-"
11/03/2015 8-K Quarterly results
Docs: "ARIAD REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS AND PROGRESS ON STRATEGIC OBJECTIVES"
09/10/2015 8-K Other Events
08/21/2015 8-K Entry into a Material Definitive Agreement
08/05/2015 8-K Quarterly results
Docs: "ARIAD REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS AND PROGRESS ON STRATEGIC OBJECTIVES"
07/29/2015 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "ARIAD TO RECEIVE UP TO $200 MILLION THROUGH ICLUSIG NON-DILUTIVE SYNTHETIC-ROYALTY FINANCING WITH PDL BIOPHARMA"
07/27/2015 8-K Other Events
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy